First-of-its-Kind Nanoparticle Platform Effectively Delivers Gene Therapies

Scientists have developed polypeptide-based materials that act as effective vectors for delivering gene therapies. The first-of-its-kind platform enables the vectors to be adapted to suit the specific gene therapy cargo.